A rapid assay for catechol oxidase and lactase using 2-nitro-5-thiobenzoic acid.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 14556)

Published in Anal Biochem on February 01, 1977

Authors

H Esterbauer, E Schwarzl, M Hayn

Articles by these authors

Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol (1990) 6.05

Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation (1995) 2.99

Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta (1980) 2.89

Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res (1987) 2.59

A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res (1989) 2.14

Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes. Biochem J (1982) 2.11

Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics (2001) 1.80

Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim Biophys Acta (1986) 1.74

Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol (1997) 1.60

Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications. Chem Phys Lipids (1988) 1.59

Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem J (1985) 1.58

Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mutat Res (1985) 1.56

Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia (2010) 1.46

Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases. Biochem J (1987) 1.44

Reaction of glutathione with conjugated carbonyls. Z Naturforsch C (1975) 1.39

Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Arteriosclerosis (1989) 1.35

Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. J Biol Chem (1986) 1.33

Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol (1995) 1.32

Monoclonal antibodies against different domains of cellobiohydrolase I and II from Trichoderma reesei. Biochim Biophys Acta (1989) 1.30

Elevated serum neopterin levels in atherosclerosis. Atherosclerosis (1991) 1.25

Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol (1984) 1.21

Thermophilic xylanase from Thermomyces lanuginosus: high-resolution X-ray structure and modeling studies. Biochemistry (1998) 1.19

Cellulose hydrolysis by the cellulases from Trichoderma reesei: a new model for synergistic interaction. Biochem J (1994) 1.18

Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem J (1985) 1.16

Cytotoxic aldehydes originating from the peroxidation of liver microsomal lipids. Identification of 4,5-dihydroxydecenal. Biochim Biophys Acta (1984) 1.14

Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med (1997) 1.13

4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem (1999) 1.12

Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis (1993) 1.12

Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res (1991) 1.11

Detection of carbonyl functions in phospholipids of liver microsomes in CCl4- and BrCCl3-poisoned rats. Biochim Biophys Acta (1982) 1.11

Immunological evidence for hypochlorite-modified proteins in human kidney. Am J Pathol (1997) 1.10

Purification and characterization of two extracellular beta-glucosidases from Trichoderma reesei. Biochim Biophys Acta (1992) 1.10

Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochim Biophys Acta (1986) 1.08

Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett (1994) 1.07

Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res (1996) 1.06

Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler Thromb (1993) 1.05

Possible role of aldehydic lipid peroxidation products as chemoattractants. Int J Tissue React (1987) 1.05

Evidence for aldehydes bound to liver microsomal protein following CCl4 or BrCCl3 poisoning. Biochim Biophys Acta (1982) 1.04

4-Hydroxynonenal formation during ischemia and reperfusion of rat small intestine. Life Sci (1995) 1.04

Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals. Biol Chem Hoppe Seyler (1986) 1.03

Hydroxyl-radical-induced iron-catalysed degradation of 2-deoxyribose. Quantitative determination of malondialdehyde. Biochem J (1988) 1.03

High-level intracellular expression of hydroxynitrile lyase from the tropical rubber tree Hevea brasiliensis in microbial hosts. Protein Expr Purif (1997) 1.02

Methods to determine oxidation of low-density lipoproteins. Methods Enzymol (1994) 1.01

Determination of fatty acids in the main lipoprotein classes by capillary gas chromatography: BF3/methanol transesterification of lyophilized samples instead of Folch extraction gives higher yields. Anal Biochem (1991) 1.00

Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J Lipid Res (1997) 1.00

Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia. Eur J Clin Invest (2008) 0.99

Possible involvement of the lipid-peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids. Biochem J (1986) 0.99

Studies on a wild strain of Schizophyllum commune: Cellulase and xylanase production and formation of the extracellular polysaccharide Schizophyllan. Biotechnol Bioeng (1987) 0.99

Brain lipid peroxidation and hydroxy radical attack following the intravenous infusion of hydrogen peroxide in an infant. Free Radic Biol Med (1996) 0.99

Effects of 4-hydroxynonenal on isolated hepatocytes. Studies on chemiluminescence response, alkane production and glutathione status. Biochem J (1983) 0.98

Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination. Biochem J (1992) 0.98

Molecular cloning of the full-length cDNA of (S)-hydroxynitrile lyase from Hevea brasiliensis. Functional expression in Escherichia coli and Saccharomyces cerevisiae and identification of an active site residue. J Biol Chem (1996) 0.97

Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat Res (1993) 0.97

Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2000) 0.97

Cytotoxicity, thiol depletion and inhibition of O6-methylguanine-DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts. Carcinogenesis (1985) 0.96

Hydroxynonenal, a component of clastogenic factors? Free Radic Biol Med (1991) 0.96

Formation and properties of reactive aldehydes. Ciba Found Symp (1978) 0.95

Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem J (1995) 0.95

Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants. Stroke (1996) 0.95

Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. J Lipid Res (1995) 0.95

Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy. Eur J Clin Invest (2007) 0.94

Comparison of the inactivation of microsomal glucose-6-phosphatase by in situ lipid peroxidation-derived 4-hydroxynonenal and exogenous 4-hydroxynonenal. Free Radic Res Commun (1986) 0.94

L-Arginine reduces lipid peroxidation in patients with diabetes mellitus. Free Radic Biol Med (1997) 0.93

Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal by mitochondria isolated from rat kidney cortex. FEBS Lett (1994) 0.92

Chemotactic activity of hydroxyalkenals on rat neutrophils. Int J Tissue React (1985) 0.92

Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDL. Biochim Biophys Acta (1995) 0.92

Investigation of lipid peroxidation in human low density lipoprotein. Free Radic Res Commun (1987) 0.91

[Experiments on the therapeutic effect of hydroxypentenal on the Ehrlich ascites solid tumor of mice]. Z Krebsforsch (1969) 0.90

The metabolism of 4-hydroxynonenal, a lipid peroxidation product, is dependent on tumor age in Ehrlich mouse ascites cells. EXS (1992) 0.90

Influence of cumene hydroperoxide and 4-hydroxynonenal on the glutathione metabolism during in vitro ageing of human skin fibroblasts. Eur J Biochem (1987) 0.90

Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans. Diabetologia (1998) 0.89

Characterization of lipoxygenase metabolites of arachidonic acid in cultured human skin fibroblasts. Biochim Biophys Acta (1984) 0.89

Interaction of 4-hydroxynonenal-modified low-density lipoproteins with the fibroblast apolipoprotein B/E receptor. Biochem J (1986) 0.89

Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein. Biochem J (1990) 0.89

Detection of 4-hydroxynonenal as a product of lipid peroxidation in native Ehrlich ascites tumor cells. Biochim Biophys Acta (1984) 0.88

Enhancement of hydrogen peroxide-induced luminol-dependent chemiluminescence by neopterin depends on the presence of iron chelator complexes. FEBS Lett (1994) 0.88

Preparation of 18O-labelled standards of hydroxy-eicosatetraenoic acids and thromboxanes for quantitative measurement by gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom (1986) 0.88

Influence of superoxide dismutase on staphylococcal arthritis--a histological and biochemical investigation using an experimental animal model. Agents Actions (1990) 0.88

Quantitative measurement of 5-, 12-, and 15-hydroxyeicosatetraenoic acid together with 12-hydroxyheptadecatrienoic acid by stable isotope dilution gas chromatography-negative ion chemical ionization-mass spectrometry. Anal Biochem (1987) 0.87

Copper can promote oxidation of LDL by markedly different mechanisms. Free Radic Biol Med (1998) 0.87

Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct (1993) 0.87

Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages. Cancer Res (1994) 0.86

Factors affecting resistance of low density lipoproteins to oxidation. Lipids (1996) 0.86

Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins. Biochim Biophys Acta (1991) 0.86

[Experiments on the therapeutical effect of 4-hydroxypentenal. 3. Inhibition of the growth of solid nemeth-kellner-lymphoma]. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1971) 0.86

Formation of N-formylkynurenine suggests the involvement of apolipoprotein B-100 centered tryptophan radicals in the initiation of LDL lipid peroxidation. FEBS Lett (1996) 0.86

Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Mutat Res (1986) 0.86

Cloning and characterization of the gene for the thermostable xylanase XynA from Thermomyces lanuginosus. J Biotechnol (1996) 0.86

The Gln27Glu polymorphism in the beta2-adrenergic receptor gene is not associated with morbid obesity in Austrian women. Int J Obes Relat Metab Disord (2000) 0.86

Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis. Free Radic Biol Med (1995) 0.86

Treatment of the budding yeast Saccharomyces cerevisiae with the lipid peroxidation product 4-HNE provokes a temporary cell cycle arrest in G1 phase. Free Radic Biol Med (1998) 0.86

[On the extensively selective in-vivo destruction of subcutaneously implanted Ehrlich ascites tumor cells using 4-hydroxy-enales, especially 4-hydroxy-pentenal]. Z Krebsforsch (1968) 0.85

[Experiments on the therapeutic effect of hydroxypentenal. II. Inhibition of the growth of sarcoma 180]. Z Krebsforsch (1971) 0.85

Disturbance of cell proliferation by two model compounds of lipid peroxidation contradicts causative role in proliferative senescence. J Cell Physiol (1988) 0.84

Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian Stroke Prevention Study. J Am Geriatr Soc (1998) 0.83

Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in thymocytes as an effective secondary antioxidative defense mechanism. J Biochem (1998) 0.83